There are about 1.2 million Americans infected with HIV, and about 350,000 of them are not yet receiving treatment, according to Aimee Tharaldson, PharmD, a senior clinical consultant in emerging therapeutics at Express Scripts.
Integrase strand transfer inhibitor (INSTI)-based regimens are recommended as initial therapy for most people with HIV. Non-nucleoside reverse transcriptase inhibitor (NNRTI)- and protease inhibitor (PI)-based regimens, are recommended in